IFNA2 and COVID-19: Of the 16 mediators elevated in early COVID-19 compared with healthy controls, 11 decreased over time (CCL3, CCL4, TNF-α, IL-6, CCL13, IL-4, IFN-α2a, CXCL10, CXCL11, IL-2, and IL-12).